Search

Benjamin J Moga

from Soquel, CA
Age ~43
Get Report
Also known as:
Benjamin Joseph Moga, Ben Moga
Phone and address:
4430 Esta Ln, Soquel, CA 95073
Related to:
Deborah L Mccormick, 64Michael Mccormick, 65Jonathan D Usher, 41Jess E Mcchesney, 51Lauren Usher, 39Claudette D UsherDianne C Usher, 67Jacqueline D Usher, 40David R Usher, 68Janine Usher, 35
Connected to:
Aaron J Moga, 49Adrian Moga, 67Beau D Moga, 46Charlie G Moga, 94Iuliana Moga, 48Leo J Moga, 63Lucian V Moga, 82Marioara Moga, 58Marta E Moga, 49Mihai Moga, 33

Benjamin Moga Phones & Addresses

  • 4430 Esta Ln, Soquel, CA 95073
  • Houston, TX
  • 304 N Segoe Rd #102, Madison, WI 53705
  • 1013 Spring St, Madison, WI 53715 (608) 256-1605
  • 2525 University Ave, Madison, WI 53705
  • 1323 Dayton St, Madison, WI 53715
  • Chippewa Falls, WI

Work

Position: Building and Grounds Cleaning and Maintenance Occupations

Resumes

Resumes

Benjamin Moga Photo 1

Benjamin Moga

View page
Location:
United States

Publications

Us Patents

Drug Delivery Device

View page
US Patent:
D638534, May 24, 2011
Filed:
Jan 8, 2010
Appl. No.:
29/353489
Inventors:
Benjamin J. Moga - Madison WI, US
Kent B. Chase - Sun Prairie WI, US
Garrick D. S. Smith - Madison WI, US
Assignee:
Ratio, Inc. - Monona WI
FluGen, Inc. - Madison WI
International Classification:
2402
US Classification:
D24113

Bladder Arrangement For Microneedle-Based Drug Delivery Device

View page
US Patent:
8328757, Dec 11, 2012
Filed:
Jan 8, 2010
Appl. No.:
12/684566
Inventors:
David J. Beebe - Monona WI, US
Benjamin J. Moga - Madison WI, US
Kent B. Chase - Sun Prairie WI, US
Garrick D. S. Smith - Madison WI, US
Jake W. Myre - Beaver Dam WI, US
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
A61M 37/01
US Classification:
604131
Abstract:
A bladder arrangement is provided for a microneedle-based drug delivery device. The bladder arrangement includes a flexible membrane having an inner surface, an outer surface and an outer periphery. A bladder member, having a rigidity greater than the flexible membrane, includes an inner surface, an outer surface and an outer periphery. The inner surface of the flexible membrane and the inner surface of the bladder member define a chamber for receiving a drug therein. At least one microneedle is operatively connected to the bladder member. The at least one microneedle has an input and an output receivable within the individual. A valve operatively connects the input of the at least one microneedle and the chamber.

Drug Delivery Platform Incorporating Hydrogel Pumping Mechanism With Guided Fluid Flow

View page
US Patent:
20100030156, Feb 4, 2010
Filed:
Aug 1, 2008
Appl. No.:
12/184632
Inventors:
David J. Beebe - Monona WI, US
Benjamin J. Moga - Madison WI, US
Tony Escarcega - Madison WI, US
Kent Chase - Sun Prairie WI, US
International Classification:
A61M 5/14
US Classification:
604182
Abstract:
A drug delivery platform is provided for delivering a controlled infusion of a drug to an individual. The drug delivery platform includes a reservoir for receiving the drug therein and a hydrogel engageable with the reservoir. The hydrogel is movable between a first configuration and a second configuration wherein the hydrogel exerts a pressure on the reservoir to urge the drug therefrom in response to a predetermined stimulus. A flow guide distributes the predetermined stimulus over the hydrogel in response to activation by an individual.

Drug Delivery Platform Utilizing Hydrogel Pumping Mechanism

View page
US Patent:
20100030198, Feb 4, 2010
Filed:
Aug 1, 2008
Appl. No.:
12/184613
Inventors:
David J. Beebe - Monona WI, US
Benjamin J. Moga - Madison WI, US
Tony Escarcega - Madison WI, US
Kent Chase - Madison WI, US
International Classification:
A61K 9/22
US Classification:
6048901
Abstract:
A drug delivery platform is provided for delivering a controlled infusion of a drug to an individual. The drug delivery platform includes a reservoir for receiving the drug therein and a pressure source engageable with the reservoir. The pressure source is movable between a first configuration and a second configuration wherein the pressure source exerts a pressure on the reservoir to urge the drug therefrom. An output conduit is provided for transmitting the drug into the individual. An actuation mechanism is operatively connected to the pressure source and the output conduit. The actuation mechanism is movable between a non-actuated position and an actuated position wherein pressure source moves from the first configuration to the second configuration and wherein the input of the output conduit communicates with the drug and the output end of the output conduit is receivable in the individual.

Biological Work Station

View page
US Patent:
20100151564, Jun 17, 2010
Filed:
Dec 12, 2008
Appl. No.:
12/333771
Inventors:
David J. Beebe - Monona WI, US
Kathryn M. Haubert - Madison WI, US
Benjamin J. Moga - Madison WI, US
International Classification:
C12M 1/00
US Classification:
4352887, 4353031
Abstract:
A biological work station for culturing and monitoring cells includes a laminar flow bench and an incubator disposed on the bench. The bench includes a work surface adjacent the incubator that allows experiments and other manipulations to be performed within the confines of the laminar flow bench. An imaging system, such as a stereoscope, may be mounted to the bench so that images may be captured of a culture without removal of the culture from the incubator.

Active Microneedle Array

View page
US Patent:
20100305518, Dec 2, 2010
Filed:
May 27, 2009
Appl. No.:
12/473028
Inventors:
Benjamin J. Moga - Madison WI, US
David J. Beebe - Monona WI, US
International Classification:
A61M 5/50
US Classification:
604272
Abstract:
An active microneedle array and method are provided for penetrating an outer layer of the epidermis. The active microneedle array includes a base having first and second sides. The first side of the base is engageable with the epidermis. A microneedle projects from the first side of the base. The microneedle is moveable between a first initial configuration and a second deformed configuration in response to engagement with the epidermis so as to form a passageway therein.

Microneedle Component Assembly For Drug Delivery Device

View page
US Patent:
20110172609, Jul 14, 2011
Filed:
Jan 8, 2010
Appl. No.:
12/684823
Inventors:
Benjamin J. Moga - Madison WI, US
Kent Chase - Sun Prairie WI, US
Garrick D.S. Smith - Madison WI, US
International Classification:
A61M 5/32
B23P 11/00
US Classification:
604272, 29428
Abstract:
A device for delivering a drug to a subject is provided. The device includes a drug reservoir, a conduit coupled to the drug reservoir and a microneedle component. The microneedle component includes a body, an engagement structure coupling the microneedle component to the conduit, a hollow microneedle extending from the body, and a handling feature located on the body. The microneedle component is configured to be releasably coupled to an assembly tool via the handling feature during assembly of the device.

Drug Delivery Device Including Tissue Support Structure

View page
US Patent:
20110172637, Jul 14, 2011
Filed:
Jan 8, 2010
Appl. No.:
12/684834
Inventors:
Benjamin J. Moga - Madison WI, US
Kent Chase - Sun Prairie WI, US
Garrick D.S. Smith - MAdison WI, US
International Classification:
A61M 5/32
US Classification:
604506, 604181, 604180, 604173
Abstract:
A drug delivery device for delivering a drug to a subject includes a microneedle configured to facilitate delivery of the drug to the subject. The microneedle includes a tip portion and is moveable from an inactive position to an activated position. When the microneedle is moved to the activated position, the tip portion of the microneedle is configured to penetrate the skin of the subject. The drug delivery device includes a tissue support structure that includes a channel and an engagement element. The channel has a first end and a second end and is in axial alignment with the microneedle. At least the tip portion of the microneedle extends past the second end of the channel in the activated position. The engagement element is positioned adjacent to the channel, and the engagement element is configured to engage with the skin of the subject such that the engagement element resists downward deformation of the skin caused by the microneedle as the microneedle moves from the inactive position to the activated position.
Control profile
Benjamin J Moga from Soquel, CA, age ~43 Get Report